Figure 3.

Seropositivity rate. The percentage of participants seropositive for antibodies against M72 at each timepoint, along with 95% CIs, is presented for participants who received M72/AS01_E and were included in the ATP cohort for immunogenicity. ATP = according-to-protocol; CI = confidence interval; D30 = 30 days post-dose 1; D60 = 30 days post-dose 2; HIV+ART+ = HIV-positive participants on antiretroviral therapy; HIV+ART- = HIV-positive, antiretroviral therapy-naïve participants; HIV− = HIV-negative participants; M7 = 6 months post-dose 2; Pre = pre-vaccination; Y1 = 1 year post-dose 2; Y2 = 2 years post-dose 2; Y3 = 3 years post-dose 2.